AI has been making inroads in drug discovery for the past decade. According to a recent analysis, biotech companies using an AI-first approach have more than 150 small-molecule drugs in discovery and more than 15 already in clinical trials
AI has been making inroads in drug discovery for the past decade. According to a recent analysis, biotech companies using an AI-first approach have more than 150 small-molecule drugs in discovery and more than 15 already in clinical trials